VEGFA and neoplasm: Chen et al. reported that anti-VEGF antibody can effectively decrease the recruitment of MDSCs to tumor tissue (113), while anti-VEGF treatment has been proposed to enhance the survival and quality of life in glioma patients (114, 115).